SCHEMBL25300066

SCHEMBL25300066

CC(=O)OC(=O)C(N)CCCNC(=N)N

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY4R P50391 8/20 0.39
NPY1R P25929 5/20 0.39
DPP7 Q9UHL4 2/20 0.38
ALOX15 P16050 1/20 0.37
NPY2R P49146 4/20 0.36
NPY5R Q15761 4/20 0.36
OTC P00480 1/20 0.35
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DDAH1 O94760 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
RRM1 P23921 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5970619 1.00 NPY4R (0.39) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL446930 1.00 NPY4R (0.39) NPY4RNPY1RDPP7ALOX15NPY2R
Hydrochloric Acid SCHEMBL4422483 0.98 NPY4R (0.38) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL4443243 0.98 NPY4R (0.38) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL8911027 0.98 NPY4R (0.38) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL9237239 0.90 NPY4R (0.39) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL288133 0.90 NPY4R (0.39) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL28712062 0.90 NPY4R (0.39) NPY4RNPY1RDPP7ALOX15NPY2R
SCHEMBL16194087 0.89 NPY4R (0.38) NPY4RNPY1RDPP7ALOX15NPY2R
Hydrochloric Acid SCHEMBL8039440 0.89 NPY4R (0.38) NPY4RNPY1RDPP7ALOX15NPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12622967-B2 Molecules, formulations, and methods for nutritional support of athletes, patients, and others TODAY, INC. (US) 2026-05-12 US disclosed
US-20240299548-A1 MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS TODAY, INC. (US) 2024-09-12 US disclosed
US-12023382-B2 Molecules, formulations, and methods for nutritional support of athletes, patients, and others Today Inc. (US) 2024-07-02 US disclosed
WO-2023139357-A1 MOLECULES, NUTRITIONAL FORMULATIONS, AND METHODS OF PROVIDING NUTRITIONAL SUPPORT Today Inc. (US) 2023-07-27 WO disclosed
US-20230226187-A1 MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS Today Inc. (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622967-B2 Molecules, formulations, and methods for nutritional support of athletes, patients, and others SLC2A9, GYS1, SLC2A8 NPY4R 1620/4885NPY1R 2512/4885DPP7 3324/4885
US-20240299548-A1 MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS CPT1B, GK, CPT1A NPY4R 843/4885NPY1R 1266/4885DPP7 4197/4885
US-20230226187-A1 MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS CPT1B, GK, CPT1A NPY4R 843/4885NPY1R 1266/4885DPP7 4197/4885
US-12023382-B2 Molecules, formulations, and methods for nutritional support of athletes, patients, and others CPT1B, GK, CPT1A NPY4R 843/4885NPY1R 1266/4885DPP7 4197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.